Thursday, July 31st, 2025

Clearbridge Health Limited Issues Corrigendum for Q3 2024 Financial Results








Clearbridge Health Limited Financial Analysis – Q3FY24

Clearbridge Health Limited Financial Analysis – Q3FY24

Business Description

Clearbridge Health Limited is incorporated in the Republic of Singapore. The company, along with its subsidiaries, operates in the healthcare sector focusing on providing healthcare solutions and services. The geographic footprint of the company and its specific business segments are not detailed in the report provided.

Industry Position and Market Share

The report does not provide specific information about Clearbridge Health Limited’s position within the industry, its competitors, or its market share. This information is critical for understanding the company’s competitive landscape and should be further investigated by potential investors.

Revenue Streams and Competitive Advantage

The report does not elaborate on the company’s revenue streams, customer base, supply chain, or competitive advantages. Investors would need to look into these aspects separately to gain a comprehensive understanding of the company’s business operations.

Financial Statement Analysis

The document provided is a corrigendum to the Q3FY24 Results Announcement and does not include the primary financial statements such as the Income Statement, Balance Sheet, or Cash Flow Statement. Therefore, an analysis of these statements is not possible from the information given.

Key Information

  • The report highlights that the striking off of the dormant subsidiary, Golden Bridge Pte. Ltd., does not have a material impact on the company’s financial position for the third quarter and nine months ended 30 September 2024, nor is it expected to impact the full year ending 31 December 2024 [[1], [2]].
  • No dividend information, earnings increase or decrease, or special activities to improve profitability are detailed in the report.

Report Date and Financial Year

The corrigendum was released on 20 November 2024, concerning the financial results for the third quarter and nine months ended 30 September 2024 [[3]].

Investment Recommendations

For Current Shareholders

If you are currently holding this stock, it is recommended to maintain your position given the lack of negative impact from recent corporate activities. However, further analysis of the complete financial statements and business operations is advised for a more informed decision.

For Potential Investors

If you are not currently holding this stock, it is recommended to wait for more comprehensive data on the company’s financial health and market position before making an investment decision. Analyzing complete financial statements and understanding the company’s competitive landscape is crucial.

Disclaimer

This recommendation is based solely on the information provided in the corrigendum document. Investors should conduct their own research and consider their financial situation before making investment decisions.




View Clearbridge Historical chart here



MSM International Reports 10.1% Revenue Decline in HY2025 Amid Challenging Market Conditions

MSM International Limited Analysis: Net Profit Decline of 75.9% MSM International Limited Analysis: Net Profit Decline of 75.9% Business Description MSM International Limited is an investment holding company headquartered in Singapore. The principal activities...

ThaiBev Reports 2.2% Revenue Growth and Stable Profits for FY2024

Thai Beverage Public Company Limited Financial Analysis – Net Profit Growth of 0.6% Thai Beverage Public Company Limited Financial Analysis – Net Profit Growth of 0.6% Business Description Thai Beverage Public Company Limited (ThaiBev)...

Sabana Industrial Real Estate Investment Trust Interim Financial Information For 1 January 2025 to 31 March 2025 Report

Sabana Industrial Real Estate Investment Trust Financial Analysis Company Overview Sabana Industrial Real Estate Investment Trust (the “Trust”) is a Singapore-domiciled unit trust constituted pursuant to a trust deed dated 29 October 2010. The...